Antivirals for Cytomegalovirus Infection in Neonates and Infants: Focus on Pharmacokinetics, Formulations, Dosing, and Adverse Events

Author： Marshall Beth C.   Koch William C.  

Publisher： Adis International

ISSN： 1174-5878

Source： Pediatric Drugs, Vol.11, Iss.5, 2009-10, pp. : 309-321

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Data on the use of antivirals to treat cytomegalovirus infection in infants are limited, with ganciclovir being the current first choice

By  

Drugs & Therapy Perspectives, Vol. 26, Iss. 5, 2010-05 ,pp. : 10-11

Adis International

Access to resources Recommend Favorite

Age-Dependent Pharmacokinetics of Lansoprazole in Neonates and Infants

By Zhang Weijiang   Kukulka Michael   Witt Galen   Sutkowski-Markmann Debra   North Janine   Atkinson Stuart  

Pediatric Drugs, Vol. 10, Iss. 4, 2008-01 ,pp. : 265-274

Adis International

Access to resources Recommend Favorite

Pharmacokinetics and Pharmacodynamics of Oseltamivir in Neonates, Infants and Children

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 13, Iss. 1, 2013-02 ,pp. : 6-14

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacokinetics of Antifungal Agents in Neonates and Young Infants

By  

Current Medicinal Chemistry, Vol. 19, Iss. 27, 2012-09 ,pp. : 4621-4632

Bentham Science Publishers

Access to resources Recommend Favorite

Development of a Physiologically Based Model for Oseltamivir and Simulation of Pharmacokinetics in Neonates and Infants

By Parrott Neil  

Clinical Pharmacokinetics, Vol. 50, Iss. 9, 2011-09 ,pp. : 613-623

Adis International

Access to resources Recommend Favorite